Hydrocortisone pretreatment for attenuation of protamine-induced adverse hemodynamic reactions.
Baraka
A
A
Choueiry
P
P
Taha
S
S
Yazbeck
V
V
Chidiac
G
G
Azar
I A
IA
Zughbi
J
J
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects; D002315:Cardiopulmonary Bypass; D001026:Coronary Artery Bypass; D006350:Heart Valve Prosthesis; D006494:Heparin Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007022:Hypotension / Q000139:chemically induced; D007275:Injections, Intravenous; D011292:Premedication; D011479:Protamines / Q000008:administration & dosage / Q000009:adverse effects*; D014655:Vascular Resistance / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D006494:Heparin Antagonists; D006633:Histamine Antagonists; D011479:Protamines; D006854:Hydrocortisone